Desk›Healthcare› Vivo Bio Tech Ltd
Vivo Bio Tech Ltd
BSE 511509 · NSE VIVOBIOT · ISIN INE380K01017 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Biotechnology
₹18.58
-0.21%
BSE close, 28 August 2026
₹41.23 cr
2.2 cr shares · Micro cap
₹18.39 cr
as published
-13.2× · 0.69×
EPS ₹-1.41 · BV ₹26.93
52.57 / -1.94
₹ cr, as filed
17
1 selected · 6%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -55.2% |
|---|---|
| Against 52-week low | +5.3% |
| Day change | -0.21% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-1.41 |
|---|---|
| Price / earnings | -13.18× |
| Price / book | 0.69× |
| Book value — derived, price ÷ P/B | ₹26.93 |
| Return on equity | -5.22% |
| Operating margin | 36.11% |
| Net margin | 1.30% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- -5.24%
- ROE as published
- -5.22%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 14.14 | 0.18 | 0.08 | 36.11% | 1.30% |
| Mar-26 · Q | 13.77 | -5.44 | -2.65 | 30.54% | -39.49% |
| FY25-26 | 52.57 | -1.94 | -0.93 | 40.06% | -3.68% |
Quarter on quarter
- Revenue, quarter on quarter
- +2.7%
- Net profit, quarter on quarter
- +103.3%
- Operating margin, quarter on quarter
- +557 bps
Disclosure profile 17 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Change in Management | 1 |
| Selected sub-total | 1 |
| Procedural | |
| General | 5 |
| AGM / EGM | 3 |
| SAST | 3 |
| Newspaper Publication | 2 |
| Annual Report | 1 |
| Compliance Certificate | 1 |
| Trading Window | 1 |
| Procedural sub-total | 16 |
| Total | 17 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
17 filings · 1 selected · busiest 2026-08-24
Filing rhythm · the twelve most recent
2026-08-242026-10-07
SelectedProcedural
Filings
17 in the window · 19 earlier on record
-
7 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Please find enclosed scrutinizer's report for 39th AGM
AGM/EGM / AGM View filing →
-
30 September 2026 ·
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find enclosed 39th AGM proceedings
AGM/EGM / AGM View filing →
-
25 September 2026 ·
Closure of Trading Window
Please find enclosed closure of trading window for quarter ended 30.09.2026
Insider Trading / SAST / Closure of Trading Window View filing →
-
10 September 2026 ·
Re-Lodgement Of Transfer Requests Of Physical Shares.
Please find enclosed report on Re-lodgement of Transfer requesrs of Physical Shares.
Company Update / General View filing →
-
9 September 2026 ·
Web Link Intimation
the company has processed the letters to the shareholders who have not registered their Email ID with the company/RTA/DP providing the web link of the annual report.
Company Update / General View filing →
-
9 September 2026 ·
Newspaper Publication
Newspaper Publication of 39th AGM Notice
Company Update / Newspaper Publication View filing →
-
8 September 2026 ·
Reg. 34 (1) Annual Report.
Please find enclosed Annual report for FY 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
8 September 2026 ·
39Th Annual General Meeting Notice.
Please find enclosed 39th Annual General Meeting Notice.
AGM/EGM / AGM View filing →
-
26 August 2026 ·
Newspaper Publication
Newspaper Publication of notice for special window for re-lodgement of transfer request of physical shares
Company Update / Newspaper Publication View filing →
-
24 August 2026 ·
-
24 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Maxcell Communication India Pvt Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
24 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dwight Technologies Pvt Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
24 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for P K L Solution Pvt Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
21 August 2026 ·
-
20 August 2026 ·
RSS feed for Vivo Bio Tech Ltd · the 50 most recent filings